The following amendment has been made to the announcement released on 03 November 2026 at 07:00:00 under RNS Number 4973B.
The amendment relates to the link for the Investor Presentation event, which should be https://www.investormeetcompany.com/cambridge-nutritional-sciences-plc/register. All other information remains unchanged.
The full amended text is shown below.
3 November 2026
Cambridge Nutritional Sciences plc
(the "Company" or "CNSL")
Half Year Results
Cambridge Nutritional Sciences plc (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, confirms it will issue its Half Year results for the six months ended 30 September 2026 on Tuesday 10 November 2026.
Investor Presentation:
On the same day at 14:00 BST James Cooper (Chief Executive Officer) and Ajay Patel (Chief Financial Officer) will host a live online presentation via the Investor Meet Company (IMC) platform to discuss the results.
The presentation is open to all existing and potential shareholders. Questions can be submitted in advance via the IMC dashboard up until 9:00 BST on 9 November 2026, or during the live event.
To register for the event and add Cambridge Nutritional Sciences plc to your watchlist please visit:
https://www.investormeetcompany.com/cambridge-nutritional-sciences-plc/register
Shareholders who already follow Cambridge Nutritional Sciences plc on the IMC platform will be automatically invited to the presentation.
Contacts:
|
Cambridge Nutritional Sciences plc |
||
|
Carolyn Rand, Non-Executive Chair |
||
|
James Cooper, Chief Executive Officer |
||
|
Ajay Patel, Chief Financial Officer |
||
|
Cavendish Capital Markets Limited |
Tel: 020 7220 0500 | |
|
Geoff Nash / Edward Whiley / (Corporate Finance) |
||
|
Nigel Birks / Harriet Ward (ECM) |
||
About Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.